Technical Analysis for BIO.B - Bio-Rad Laboratories, Inc. Class B
|Grade||Last Price||% Change||Price Change|
BIO.B closed down 2.04 percent on Wednesday, October 18, 2017, on 1.13 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Nov 7
|See historical BIO.B trend table...|
|Date||Alert Name||Type||% Chg|
|Oct 18||Narrow Range Bar||Range Contraction||0.00%|
|Oct 18||Lower Bollinger Band Walk||Other||0.00%|
|Oct 18||MACD Bearish Centerline Cross||Bearish||0.00%|
|Oct 18||Calm After Storm||Range Contraction||0.00%|
|Oct 17||Narrow Range Bar||Range Contraction||-2.04%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more BIO.B news...
|52 Week High||240.5|
|52 Week Low||149.45|
|200-Day Moving Average||208.8814|
|50-Day Moving Average||223.0978|
|20-Day Moving Average||227.0085|
|10-Day Moving Average||226.007|
|Average True Range||2.12|
|Chandelier Exit (Long, 3 ATRs )||223.79|
|Chandelier Exit (Short, 3 ATRs )||224.66|
|Upper Bollinger Band||232.0578|
|Lower Bollinger Band||221.9592|
|Percent B (%b)||-0.36|
|MACD Signal Line||0.9538|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||218.30|
|Resistance 3 (R3)||218.30||218.30||218.30|
|Resistance 2 (R2)||218.30||218.30||218.30||218.30|
|Resistance 1 (R1)||218.30||218.30||218.30||218.30||218.30|
|Support 1 (S1)||218.30||218.30||218.30||218.30||218.30|
|Support 2 (S2)||218.30||218.30||218.30||218.30|
|Support 3 (S3)||218.30||218.30||218.30|
|Support 4 (S4)||218.30|